Khiron Life Sciences Aktie

Khiron Life Sciences Corp. engages in the vertically integrated medical and consumer packaged goods cannabis company with core operations in Latin America and operational activities in Europe and North America. It provides medical cannabis in Colombia and focuses on the cultivation, production, international export, domestic distribution and sale of tetrahydrocannabinolmedical cannabis products. It operates through the following segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The Medical Cannabis Products segment focuses on the growth, production and sale of branded products and services to patients with medical conditions where cannabis can be an acceptable, proven option. The Health Services segment includes medium complexity health centers offering a suite of health, medical and surgical services in alignment with insurance company partners. The Wellbeing Products segment refers to delivering the benefits of CBD and hemp across an array of various brand